Factor Therapeutics Limited provided an update on the company's proposed acquisition of PowerLime Inc. and re-listing on the ASX. As soon as practicable after the Company's readmission to ASX the Board intends to appoint Mr. Dominic Allen as an Executive Director, and Mr. Anastasios Arima as a Non-Executive Director, of the Company. Mr. John Michailidis and Mr. Melanie Farris will retire from the Board upon the Company's readmission to ASX. Mr. Allen is a finance professional with over 15 years experience in the management and operations of natural resources organisations. Mr. Allen is currently Head of Corporate Development for Hyperion Metals. Mr. Arima is a resource company executive with a strong history of identifying company-making resource projects. He was the founder of Piedmont Lithium. Mr. Arima is the founder and Managing Director of Hyperion Metals.